|
Mammalian Phenotype (MP): abnormal immune system physiology
(show info)
Phenotype Ontology
Like Gene Ontology (GO), phenotypy ontology classifies and organizes gene-mutant/null phenotypic information from the very general at the top to more specific terms in the directed acyclic graph (DAG) by viewing an individual term as a node and its relations to parental terms (allowing for multiple parents) as directed edges. To navigate this hierarchy, we display all parental phenotypic terms to the current phenotypic term of interest ordered by their shortest distances to the current term. Also, only direct children phenotypic terms of the current phenotypic term are listed. Phenotype ontologies we have incorporated are as follows:
- Disease Ontology (DO) Ontology (DO) DO semantically integrates disease and medical vocabularies through extensive cross mapping of DO terms to MeSH, ICD, NCI thesaurus, SNOMED and OMIM.
- Human Phenotype (HP) Ontology (HP) HP captures phenotypic abnormalities that are described in OMIM, along with the corresponding disease-causing genes. It includes three complementary biological concepts: Mode_of_Inheritance (MI), ONset_and_clinical_course (ON), and Phenotypic_Abnormality (PA).
- Mouse Phenotype (MP) Ontology (MP) MP describes phenotypes of the mouse after a specific gene is genetically disrupted. Using it, Mouse Genome Informatics (MGI) provides high-coverate gene-level phenotypes for the mouse.
- Worm Phenotype (WP) Ontology (WP) WP classifies and organizes phenotype descriptions for C. elegans and other nematodes. Using it, WormBase provides primary resource for phenotype annotations for C. elegans.
- Yeast Phenotype (YP) Ontology (YP) Based on YP which is the major contributor to the Ascomycete phenotype ontology, Saccharomyces Genome Database (SGD) provides single mutant phenotypes for every gene in the yeast genome.
- Fly Phenotype (FP) Ontology (FP) FP refers to FlyBase controlled vocabulary. Specifically, a structured controlled vocabulary is used for the annotation of alleles (for their mutagen etc) in FlyBase.
- Fly Anatomy (FA) Ontology (FA) FA is a structured controlled vocabulary of the anatomy of Drosophila melanogaster, used for the description of phenotypes and where a gene is expressed.
- Zebrafish Anatomy (ZA) Ontology (ZA) ZA displays anatomical terms of the zebrafish using standard anatomical nomenclature, together with affected genes.
- Xenopus Anatomy (XA) Ontology (XA) XA represents the lineage of tissues and the timing of development for frogs (Xenopus laevis and Xenopus tropicalis). It is used to annotate Xenopus gene expression patterns and mutant and morphant phenotypes.
- Arabidopsis Plant Ontology (AP) Ontology (AP) As a major contributor to Plant Ontology which describes plant anatomical and morphological structures (AN) and growth and developmental stages (DE), the Arabidopsis Information Resource (TAIR) provides arabidopsis plant ontology annotations for the model higher plant Arabidopsis thaliana.
- Enzyme Commission (EC) Ontology (EC) Each enzyme is allocated a four-digit EC number, the first three digits of which define the reaction catalysed and the fourth of which is a unique identifier (serial number). Each enzyme is also assigned a systematic name that uniquely defines the reaction catalysed.
- DrugBank ATC (DB) Ontology (DB) In the Anatomical Therapeutic Chemical (ATC) classification system, drugs are classified in groups at five different levels according to the organ or system (1st level, anatomical main group) on which they act and their therapeutic (2nd level, therapeutic subgroup), pharmacological (3rd level, pharmacological subgroup) and chemical properties (4th level, chemical subgroup; 5th level, chemical substance). Only drugs in DrugBank are considered.
- UniProtKB KeyWords (KW) Ontology (KW) Keywords in UniProtKB are controlled vocabulary, providing a summary of the entry content and are used to index UniProtKB/Swiss-Prot entries based on 10 categories (the category "Technical term" being excluded here). Each keyword is attributed manually to UniProtKB/Swiss-Prot entries and automatically to UniProtKB/TrEMBL entries (according to specific annotation rules).
- UniProtKB UniPathway (UP) Ontology (UP) UP is a fully manually curated resource for the representation and annotation of metabolic pathways, being used as controlled vocabulary for pathway annotation in UniProtKB.
Structural Domain Phenotype Ontology and its Annotations
Structural Classification of Proteins (SCOP) classifies evolutionary-related domains into Superfamily level and Family level. Using the phenotype ontologies above, we have generated the domain-centric phenotype annotations, and further identified those phenotype terms which are the most informative to annotate SCOP domains. Promisingly, domain-centric phenotypic annotations can serve as an alternative starting point to explore genotype-phenotype relationships. We provide several relevant files for the download, including the annotation and the corresponding ontology for each phenotype ontology.
- Structural Domain Disease Ontology (DO) Ontology (SDDO) and its Annotations: For details, please visit Document: PO annotation for SCOP domains, wherein Data Availability contains parsable flat files (the annotation:Domain2DO.txt, and the corresponding ontology:SDDO.txt) and mysql tables (Domain2PO.sql.gz).
- Structural Domain Human Phenotype (HP) Ontology (SDHP) and its Annotations: For details, please visit Document: PO annotation for SCOP domains, wherein Data Availability contains parsable flat files (the annotation:Domain2HP.txt, and the corresponding ontology:SDHP.txt) and mysql tables (Domain2PO.sql.gz).
- Structural Domain Mouse Phenotype (MP) Ontology (SDMP) and its Annotations: For details, please visit Document: PO annotation for SCOP domains, wherein Data Availability contains parsable flat files (the annotation:Domain2MP.txt, and the corresponding ontology:SDMP.txt) and mysql tables (Domain2PO.sql.gz).
- Structural Domain Worm Phenotype (WP) Ontology (SDWP) and its Annotations: For details, please visit Document: PO annotation for SCOP domains, wherein Data Availability contains parsable flat files (the annotation:Domain2WP.txt, and the corresponding ontology:SDWP.txt) and mysql tables (Domain2PO.sql.gz).
- Structural Domain Yeast Phenotype (YP) Ontology (SDYP) and its Annotations: For details, please visit Document: PO annotation for SCOP domains, wherein Data Availability contains parsable flat files (the annotation:Domain2YP.txt, and the corresponding ontology:SDYP.txt) and mysql tables (Domain2PO.sql.gz).
- Structural Domain Fly Phenotype (FP) Ontology (SDFP) and its Annotations: For details, please visit Document: PO annotation for SCOP domains, wherein Data Availability contains parsable flat files (the annotation:Domain2FP.txt, and the corresponding ontology:SDFP.txt) and mysql tables (Domain2PO.sql.gz).
- Structural Domain Fly Anatomy (FA) Ontology (SDFA) and its Annotations: For details, please visit Document: PO annotation for SCOP domains, wherein Data Availability contains parsable flat files (the annotation:Domain2FA.txt, and the corresponding ontology:SDFA.txt) and mysql tables (Domain2PO.sql.gz).
- Structural Domain Zebrafish Anatomy (ZA) Ontology (SDZA) and its Annotations: For details, please visit Document: PO annotation for SCOP domains, wherein Data Availability contains parsable flat files (the annotation:Domain2ZA.txt, and the corresponding ontology:SDZA.txt) and mysql tables (Domain2PO.sql.gz).
- Structural Domain Xenopus Anatomy (XA) Ontology (SDXA) and its Annotations: For details, please visit Document: PO annotation for SCOP domains, wherein Data Availability contains parsable flat files (the annotation:Domain2XA.txt, and the corresponding ontology:SDXA.txt) and mysql tables (Domain2PO.sql.gz).
- Structural Domain Arabidopsis Plant Ontology (AP) Ontology (SDAP) and its Annotations: For details, please visit Document: PO annotation for SCOP domains, wherein Data Availability contains parsable flat files (the annotation:Domain2AP.txt, and the corresponding ontology:SDAP.txt) and mysql tables (Domain2PO.sql.gz).
- Structural Domain Enzyme Commission (EC) Ontology (SDEC) and its Annotations: For details, please visit Document: PO annotation for SCOP domains, wherein Data Availability contains parsable flat files (the annotation:Domain2EC.txt, and the corresponding ontology:SDEC.txt) and mysql tables (Domain2PO.sql.gz).
- Structural Domain DrugBank ATC (DB) Ontology (SDDB) and its Annotations: For details, please visit Document: PO annotation for SCOP domains, wherein Data Availability contains parsable flat files (the annotation:Domain2DB.txt, and the corresponding ontology:SDDB.txt) and mysql tables (Domain2PO.sql.gz).
- Structural Domain UniProtKB KeyWords (KW) Ontology (SDKW) and its Annotations: For details, please visit Document: PO annotation for SCOP domains, wherein Data Availability contains parsable flat files (the annotation:Domain2KW.txt, and the corresponding ontology:SDKW.txt) and mysql tables (Domain2PO.sql.gz).
- Structural Domain UniProtKB UniPathway (UP) Ontology (SDUP) and its Annotations: For details, please visit Document: PO annotation for SCOP domains, wherein Data Availability contains parsable flat files (the annotation:Domain2UP.txt, and the corresponding ontology:SDUP.txt) and mysql tables (Domain2PO.sql.gz).
Supra-domain Phenotype Ontology and its Annotations
Although domain-centric annotations hold great promise in describing phenotypic nature of independent domains, most domains themselves may not just work alone. In multi-domain proteins, they may be combined together to form distinct domain architectures. The recombination of the existing domains is considered as one of major driving forces for phenotypic diversificaation. As an extension, we have also generated supra-domain phenotype ontology and its annotations. Compared to domain-centric phenotype ontology and annotations (SCOP domains at the Superfamily level and Family level), this version focuses on supra-domains and individual SCOP domains ONLY at the Superfamily level. Besides, in terms of individual superfamilies, their annotations from the domain-centric version may be different from those from supra-domains version. Depending on your focus, the former should be used for the consideration of both the Superfamily level and Family level, otherwise the latter should be used if you are interested in domain combinations. Also, we provide several relevant files for the download, including the annotation and the corresponding ontology for each phenotype ontology.
- Supra-domain Domain Disease Ontology (DO) Ontology (SPDO) and its Annotations: For details, please visit Document: PO annotation for Supra-domains, wherein Data Availability contains parsable flat files (the annotation:SP2DO.txt, and the corresponding ontology:SPDO.txt) and mysql tables (SP2PO.sql.gz).
- Supra-domain Domain Human Phenotype (HP) Ontology (SPHO) and its Annotations: For details, please visit Document: PO annotation for Supra-domains, wherein Data Availability contains parsable flat files (the annotation:SP2HP.txt, and the corresponding ontology:SPHO.txt) and mysql tables (SP2PO.sql.gz).
- Supra-domain Domain Mouse Phenotype (MP) Ontology (SPMP) and its Annotations: For details, please visit Document: PO annotation for Supra-domains, wherein Data Availability contains parsable flat files (the annotation:SP2MP.txt, and the corresponding ontology:SPMP.txt) and mysql tables (SP2PO.sql.gz).
- Supra-domain Domain Worm Phenotype (WP) Ontology (SPWP) and its Annotations: For details, please visit Document: PO annotation for Supra-domains, wherein Data Availability contains parsable flat files (the annotation:SP2WP.txt, and the corresponding ontology:SPWP.txt) and mysql tables (SP2PO.sql.gz).
- Supra-domain Domain Yeast Phenotype (YP) Ontology (SPYP) and its Annotations: For details, please visit Document: PO annotation for Supra-domains, wherein Data Availability contains parsable flat files (the annotation:SP2YP.txt, and the corresponding ontology:SPYP.txt) and mysql tables (SP2PO.sql.gz).
- Supra-domain Domain Fly Phenotype (FP) Ontology (SPFP) and its Annotations: For details, please visit Document: PO annotation for Supra-domains, wherein Data Availability contains parsable flat files (the annotation:SP2FP.txt, and the corresponding ontology:SPFP.txt) and mysql tables (SP2PO.sql.gz).
- Supra-domain Domain Fly Anatomy (FA) Ontology (SPFA) and its Annotations: For details, please visit Document: PO annotation for Supra-domains, wherein Data Availability contains parsable flat files (the annotation:SP2FA.txt, and the corresponding ontology:SPFA.txt) and mysql tables (SP2PO.sql.gz).
- Supra-domain Domain Zebrafish Anatomy (ZA) Ontology (SPZA) and its Annotations: For details, please visit Document: PO annotation for Supra-domains, wherein Data Availability contains parsable flat files (the annotation:SP2ZA.txt, and the corresponding ontology:SPZA.txt) and mysql tables (SP2PO.sql.gz).
- Supra-domain Domain Xenopus Anatomy (XA) Ontology (SPXA) and its Annotations: For details, please visit Document: PO annotation for Supra-domains, wherein Data Availability contains parsable flat files (the annotation:SP2XA.txt, and the corresponding ontology:SPXA.txt) and mysql tables (SP2PO.sql.gz).
- Supra-domain Domain Arabidopsis Plant Ontology (AP) Ontology (SPAP) and its Annotations: For details, please visit Document: PO annotation for Supra-domains, wherein Data Availability contains parsable flat files (the annotation:SP2AP.txt, and the corresponding ontology:SPAP.txt) and mysql tables (SP2PO.sql.gz).
- Supra-domain Domain Enzyme Commission (EC) Ontology (SPEC) and its Annotations: For details, please visit Document: PO annotation for Supra-domains, wherein Data Availability contains parsable flat files (the annotation:SP2EC.txt, and the corresponding ontology:SPEC.txt) and mysql tables (SP2PO.sql.gz).
- Supra-domain Domain DrugBank ATC (DB) Ontology (SPDB) and its Annotations: For details, please visit Document: PO annotation for Supra-domains, wherein Data Availability contains parsable flat files (the annotation:SP2DB.txt, and the corresponding ontology:SPDB.txt) and mysql tables (SP2PO.sql.gz).
- Supra-domain Domain UniProtKB KeyWords (KW) Ontology (SPKW) and its Annotations: For details, please visit Document: PO annotation for Supra-domains, wherein Data Availability contains parsable flat files (the annotation:SP2KW.txt, and the corresponding ontology:SPKW.txt) and mysql tables (SP2PO.sql.gz).
- Supra-domain Domain UniProtKB UniPathway (UP) Ontology (SPUP) and its Annotations: For details, please visit Document: PO annotation for Supra-domains, wherein Data Availability contains parsable flat files (the annotation:SP2UP.txt, and the corresponding ontology:SPUP.txt) and mysql tables (SP2PO.sql.gz).
Jump to [ Top · Phenotype Hierarchy · Superfamily · Family · Supra-domain ]
Root: MP Hierarchy (mammalian/mouse phenotype from MGI_4.41)
Jump to [ Top · Phenotype Hierarchy · Superfamily · Family · Supra-domain ]
Superfamily(show details)
Superfamily domains annotated to this MP term (Not in SDMP)
Highlighted in gray are those with FDR_all>0.001
Jump to [ Top · Phenotype Hierarchy · Superfamily · Family · Supra-domain ]
Family(show details)
Family domains annotated to this MP term (Not in SDMP)
Highlighted in gray are those with FDR_all>0.001
SCOP term | FDR (all) | Annotation (direct or inherited) |
Anaphylotoxins (complement system) | 0 | DIRECT |
Cysteine rich domain | 0 | DIRECT |
p53 DNA-binding domain-like | 0 | DIRECT |
Nitric oxide (NO) synthase oxygenase domain | 0 | DIRECT |
Proteasome subunits | 0 | DIRECT |
STAT DNA-binding domain | 0 | DIRECT |
Interleukin-1 (IL-1) | 0 | DIRECT |
Transcription factor STAT-4 N-domain | 0 | DIRECT |
STAT | 0 | DIRECT |
p53 tetramerization domain | 0 | DIRECT |
Interleukin 17F, IL-17F | 0 | DIRECT |
N-acetylmuramoyl-L-alanine amidase-like | 0 | DIRECT |
Resistin | 0 | DIRECT |
Toll/Interleukin receptor TIR domain | 0.00000000001054 | DIRECT |
TNF receptor-like | 0.00000002492 | DIRECT |
Rel/Dorsal transcription factors, DNA-binding domain | 0.00003699 | DIRECT |
Interferon regulatory factor | 0.0001156 | DIRECT |
Caspase recruitment domain, CARD | 0.0001403 | DIRECT |
Caspase catalytic domain | 0.0002311 | DIRECT |
TNF-like | 0.0002428 | DIRECT |
DEATH domain, DD | 0.0004761 | DIRECT |
C-type lectin domain | 0.0005266 | DIRECT |
NF-kappa-B/REL/DORSAL transcription factors, C-terminal domain | 0.0008924 | DIRECT |
Interferon regulatory factor 3 (IRF3), transactivation domain | 0.001049 | INHERITED FROM: abnormal circulating cytokine level || abnormal interferon secretion || altered susceptibility to infection || increased susceptibility to viral infection || abnormal immune serum protein physiology || abnormal T cell physiology || abnormal response to infection |
Complement components | 0.001049 | INHERITED FROM: increased inflammatory response || abnormal inflammatory response || increased susceptibility to bacterial infection |
Alpha-macroglobulin receptor domain | 0.001049 | INHERITED FROM: increased inflammatory response || abnormal inflammatory response || increased susceptibility to bacterial infection |
Interferons/interleukin-10 (IL-10) | 0.001734 | INHERITED FROM: increased interleukin-12 secretion || increased susceptibility to induced colitis || increased tumor necrosis factor secretion || decreased interleukin-10 secretion || increased susceptibility to infection || abnormal circulating cytokine level || lung inflammation || altered susceptibility to infection || colitis || abnormal susceptibility to induced colitis || altered susceptibility to bacterial infection || abnormal cytokine secretion |
Inhibitor of apoptosis (IAP) repeat | 0.003065 | INHERITED FROM: abnormal cell-mediated immunity || abnormal B cell apoptosis || abnormal adaptive immunity || abnormal immune cell physiology || abnormal lymphocyte physiology || abnormal leukocyte physiology |
SH3-domain | 0.00375 | INHERITED FROM: abnormal cell-mediated immunity || decreased interleukin-2 secretion || abnormal interleukin-2 secretion || abnormal B cell proliferation || abnormal neutrophil physiology || abnormal adaptive immunity || abnormal immune cell physiology |
Rhodopsin-like | 0.008347 | INHERITED FROM: abnormal acute inflammation || decreased inflammatory response || abnormal leukocyte migration || abnormal type I hypersensitivity reaction || abnormal hypersensitivity reaction |
SH2 domain | 0.008586 | INHERITED FROM: abnormal cell-mediated immunity || abnormal interferon-gamma secretion || autoimmune response || abnormal circulating cytokine level || abnormal level of surface class II molecules || abnormal B cell proliferation || abnormal self tolerance || increased circulating interleukin-17 level || abnormal NK cell physiology || increased B cell apoptosis || abnormal B cell apoptosis || impaired natural killer cell mediated cytotoxicity || increased circulating interleukin-12 level || abnormal adaptive immunity || abnormal immune serum protein physiology || abnormal immune cell physiology || abnormal circulating interferon-gamma level |
PLC-like (P variant) | 0.009302 | INHERITED FROM: decreased interleukin-2 secretion || autoimmune response || abnormal B cell proliferation || decreased interferon-gamma secretion || abnormal cytotoxic T cell cytolysis || kidney inflammation |
C2 set domains | 0.01199 | INHERITED FROM: decreased susceptibility to autoimmune disorder || decreased susceptibility to autoimmune diabetes |
Triple coiled coil domain of C-type lectins | 0.02349 | INHERITED FROM: increased susceptibility to infection || abnormal cytokine level || altered susceptibility to infection || abnormal response to infection |
Cytochrome p450 reductase N-terminal domain-like | 0.02349 | INHERITED FROM: abnormal macrophage physiology || abnormal osteoclast physiology || abnormal innate immunity |
Fibronectin type III | 0.02492 | INHERITED FROM: autoimmune response || abnormal circulating cytokine level || abnormal self tolerance || abnormal circulating interferon-gamma level |
V set domains (antibody variable domain-like) | 0.02698 | INHERITED FROM: abnormal interferon-gamma secretion || CNS inflammation || autoimmune response || brain inflammation || abnormal T cell proliferation || decreased IgG2a level || abnormal immune tolerance || insulitis || increased T cell proliferation |
WWE domain | 0.02774 | INHERITED FROM: abnormal B cell proliferation || abnormal B cell activation |
Transducin (alpha subunit), insertion domain | 0.02964 | INHERITED FROM: increased tumor necrosis factor secretion || increased interleukin-2 secretion |
I set domains | 0.04549 | INHERITED FROM: increased IgG1 level |
Short-chain cytokines | 0.05116 | INHERITED FROM: abnormal splenocyte physiology || abnormal interferon-gamma secretion || decreased interleukin-5 secretion || increased anti-double stranded DNA antibody level || increased susceptibility to infection || autoimmune response || abnormal antigen presentation || altered susceptibility to parasitic infection || increased IgG2a level || abnormal interferon secretion || granulomatous inflammation || increased anti-nuclear antigen antibody level || abnormal professional antigen presenting cell physiology || lung inflammation || altered susceptibility to infection || abnormal IgE level || abnormal self tolerance || increased susceptibility to parasitic infection || abnormal IgG2b level || decreased susceptibility to type IV hypersensitivity reaction || abnormal IgG2a level || glomerulonephritis || abnormal response to transplant || increased IgG2b level || abnormal spleen physiology || abnormal leukocyte physiology |
MMP N-terminal domain | 0.05116 | INHERITED FROM: altered susceptibility to infection || arthritis || altered susceptibility to bacterial infection |
Hemopexin-like domain | 0.05116 | INHERITED FROM: altered susceptibility to infection || arthritis || altered susceptibility to bacterial infection |
Matrix metalloproteases, catalytic domain | 0.05116 | INHERITED FROM: altered susceptibility to infection || arthritis || altered susceptibility to bacterial infection |
Pleckstrin-homology domain (PH domain) | 0.05159 | INHERITED FROM: abnormal cell-mediated immunity || decreased interleukin-2 secretion || abnormal B cell proliferation |
EF-hand modules in multidomain proteins | 0.06427 | INHERITED FROM: increased interleukin-2 secretion |
NADPH-cytochrome p450 reductase-like | 0.06482 | INHERITED FROM: abnormal macrophage physiology || abnormal osteoclast physiology |
Netrin-like domain (NTR/C345C module) | 0.06482 | INHERITED FROM: increased susceptibility to infection || autoimmune response || abnormal self tolerance || abnormal immune tolerance || altered susceptibility to bacterial infection || increased susceptibility to bacterial infection |
NADPH-cytochrome p450 reductase FAD-binding domain-like | 0.06482 | INHERITED FROM: abnormal macrophage physiology || abnormal osteoclast physiology |
Fibronectin type II module | 0.08185 | INHERITED FROM: decreased susceptibility to infection |
Integrin A (or I) domain | 0.0867 | INHERITED FROM: abnormal leukocyte migration |
Papain-like | 0.09751 | INHERITED FROM: salivary gland inflammation || pancreas inflammation || decreased susceptibility to autoimmune diabetes || insulitis |
Eukaryotic proteases | 0.09763 | INHERITED FROM: abnormal complement pathway || altered susceptibility to infection |
28-residue LRR | 0.1038 | INHERITED FROM: abnormal cell-mediated immunity || abnormal circulating interleukin level || abnormal interleukin secretion || colitis || abnormal susceptibility to induced colitis || abnormal adaptive immunity || abnormal immune serum protein physiology || abnormal immune cell physiology || large intestinal inflammation || abnormal interleukin-1 beta secretion || abnormal leukocyte physiology |
Noncollagenous (NC1) domain of collagen IV | 0.1206 | INHERITED FROM: kidney inflammation |
Kringle modules | 0.1327 | INHERITED FROM: abnormal acute phase protein level |
Interleukin 8-like chemokines | 0.1339 | INHERITED FROM: abnormal leukocyte physiology |
C1 set domains (antibody constant domain-like) | 0.158 | INHERITED FROM: abnormal interferon-gamma secretion || abnormal IgG level || autoimmune response || abnormal antigen presentation || altered susceptibility to infection || altered susceptibility to autoimmune disorder || abnormal self tolerance || abnormal B lymphocyte antigen presentation || abnormal cytotoxic T cell physiology || abnormal leukocyte physiology |
VWC domain | 0.1642 | INHERITED FROM: increased inflammatory response |
Bcl-2 inhibitors of programmed cell death | 0.1642 | INHERITED FROM: abnormal IgG level || abnormal B cell physiology || abnormal T cell physiology || abnormal T cell apoptosis || abnormal spleen physiology |
Long-chain cytokines | 0.1642 | INHERITED FROM: increased susceptibility to infection || autoimmune response || abnormal circulating cytokine level || abnormal cytokine level || altered susceptibility to autoimmune disorder || abnormal self tolerance || altered susceptibility to bacterial infection || decreased susceptibility to experimental autoimmune encephalomyelitis |
DBL homology domain (DH-domain) | 0.1852 | INHERITED FROM: decreased interleukin-2 secretion || decreased B cell proliferation |
MHC antigen-recognition domain | 0.1856 | INHERITED FROM: abnormal interferon-gamma secretion || abnormal natural killer cell mediated cytotoxicity || abnormal antigen presentation || abnormal interferon secretion || altered susceptibility to infection || altered susceptibility to autoimmune disorder || abnormal B lymphocyte antigen presentation || abnormal lymphocyte physiology || abnormal cytotoxic T cell physiology || abnormal leukocyte physiology |
Integrin domains | 0.1856 | INHERITED FROM: abnormal cellular extravasation || abnormal leukocyte migration |
Integrin beta tail domain | 0.2063 | INHERITED FROM: increased inflammatory response || abnormal leukocyte migration || abnormal inflammatory response |
Integrin beta EGF-like domains | 0.2063 | INHERITED FROM: increased inflammatory response || abnormal leukocyte migration || abnormal inflammatory response |
Pyrin domain, PYD | 0.2063 | INHERITED FROM: abnormal cell-mediated immunity || abnormal interferon-gamma secretion || abnormal circulating interleukin-1 beta level || decreased interleukin-1 beta secretion || abnormal circulating interleukin-18 level || decreased circulating interleukin-18 level || abnormal interleukin-18 secretion || abnormal inflammatory response || abnormal circulating interleukin level || abnormal interleukin secretion || colitis || abnormal susceptibility to induced colitis || abnormal adaptive immunity || abnormal immune serum protein physiology || abnormal immune cell physiology || large intestinal inflammation || abnormal interleukin-1 beta secretion || abnormal leukocyte physiology |
Integrin alpha N-terminal domain | 0.2214 | INHERITED FROM: abnormal cellular extravasation |
Phoshoinositide 3-kinase (PI3K), catalytic domain | 0.2644 | INHERITED FROM: decreased B cell proliferation || abnormal lymphocyte physiology |
Ngr ectodomain-like | 0.2928 | INHERITED FROM: osteoarthritis |
Complement control module/SCR domain | 0.3548 | INHERITED FROM: abnormal eosinophil physiology || impaired leukocyte tethering or rolling || abnormal complement pathway || abnormal leukocyte tethering or rolling || impaired eosinophil recruitment || abnormal innate immunity |
Double-stranded RNA-binding domain (dsRBD) | 0.39 | INHERITED FROM: increased susceptibility to viral infection |
Notch domain | 0.4082 | INHERITED FROM: abnormal interleukin secretion |
Cell cycle control phosphatase, catalytic domain | 0.476 | INHERITED FROM: increased tumor necrosis factor secretion |
Nuclear receptor ligand-binding domain | 0.4853 | INHERITED FROM: large intestinal inflammation |
Nuclear receptor | 0.4853 | INHERITED FROM: large intestinal inflammation |
EGF-type module | 0.5976 | INHERITED FROM: abnormal leukocyte adhesion |
FHA domain | 0.6354 | INHERITED FROM: abnormal class switch recombination |
RING finger domain, C3HC4 | 0.8331 | INHERITED FROM: skin inflammation || dermatitis || increased interleukin-2 secretion |
CCCH zinc finger | 0.8567 | INHERITED FROM: increased circulating tumor necrosis factor level || abnormal circulating tumor necrosis factor level |
Transforming growth factor (TGF)-beta | 0.8618 | INHERITED FROM: granulomatous inflammation || chronic inflammation |
ets domain | 0.8951 | INHERITED FROM: abnormal B cell proliferation || increased B cell apoptosis |
Nicotinic receptor ligand binding domain-like | 0.9351 | INHERITED FROM: urinary bladder inflammation |
Neurotransmitter-gated ion-channel transmembrane pore | 0.9351 | INHERITED FROM: urinary bladder inflammation |
SCOP term | FDR (all) | Annotation (direct or inherited) |
Anaphylotoxins (complement system) | 0 | Direct |
Cysteine rich domain | 0 | Direct |
p53 DNA-binding domain-like | 0 | Direct |
Nitric oxide (NO) synthase oxygenase domain | 0 | Direct |
Proteasome subunits | 0 | Direct |
STAT DNA-binding domain | 0 | Direct |
Interleukin-1 (IL-1) | 0 | Direct |
Transcription factor STAT-4 N-domain | 0 | Direct |
STAT | 0 | Direct |
p53 tetramerization domain | 0 | Direct |
Interleukin 17F, IL-17F | 0 | Direct |
N-acetylmuramoyl-L-alanine amidase-like | 0 | Direct |
Resistin | 0 | Direct |
Toll/Interleukin receptor TIR domain | 0.00000000001054 | Direct |
TNF receptor-like | 0.00000002492 | Direct |
Rel/Dorsal transcription factors, DNA-binding domain | 0.00003699 | Direct |
Interferon regulatory factor | 0.0001156 | Direct |
Caspase recruitment domain, CARD | 0.0001403 | Direct |
Caspase catalytic domain | 0.0002311 | Direct |
TNF-like | 0.0002428 | Direct |
DEATH domain, DD | 0.0004761 | Direct |
C-type lectin domain | 0.0005266 | Direct |
NF-kappa-B/REL/DORSAL transcription factors, C-terminal domain | 0.0008924 | Direct |
Interferon regulatory factor 3 (IRF3), transactivation domain | 0.001049 | Inherited |
Complement components | 0.001049 | Inherited |
Alpha-macroglobulin receptor domain | 0.001049 | Inherited |
Interferons/interleukin-10 (IL-10) | 0.001734 | Inherited |
Inhibitor of apoptosis (IAP) repeat | 0.003065 | Inherited |
SH3-domain | 0.00375 | Inherited |
Rhodopsin-like | 0.008347 | Inherited |
SH2 domain | 0.008586 | Inherited |
PLC-like (P variant) | 0.009302 | Inherited |
C2 set domains | 0.01199 | Inherited |
Triple coiled coil domain of C-type lectins | 0.02349 | Inherited |
Cytochrome p450 reductase N-terminal domain-like | 0.02349 | Inherited |
Fibronectin type III | 0.02492 | Inherited |
V set domains (antibody variable domain-like) | 0.02698 | Inherited |
WWE domain | 0.02774 | Inherited |
Transducin (alpha subunit), insertion domain | 0.02964 | Inherited |
I set domains | 0.04549 | Inherited |
Short-chain cytokines | 0.05116 | Inherited |
MMP N-terminal domain | 0.05116 | Inherited |
Hemopexin-like domain | 0.05116 | Inherited |
Matrix metalloproteases, catalytic domain | 0.05116 | Inherited |
Pleckstrin-homology domain (PH domain) | 0.05159 | Inherited |
EF-hand modules in multidomain proteins | 0.06427 | Inherited |
NADPH-cytochrome p450 reductase-like | 0.06482 | Inherited |
Netrin-like domain (NTR/C345C module) | 0.06482 | Inherited |
NADPH-cytochrome p450 reductase FAD-binding domain-like | 0.06482 | Inherited |
Fibronectin type II module | 0.08185 | Inherited |
Integrin A (or I) domain | 0.0867 | Inherited |
Papain-like | 0.09751 | Inherited |
Eukaryotic proteases | 0.09763 | Inherited |
28-residue LRR | 0.1038 | Inherited |
Noncollagenous (NC1) domain of collagen IV | 0.1206 | Inherited |
Kringle modules | 0.1327 | Inherited |
Interleukin 8-like chemokines | 0.1339 | Inherited |
C1 set domains (antibody constant domain-like) | 0.158 | Inherited |
VWC domain | 0.1642 | Inherited |
Bcl-2 inhibitors of programmed cell death | 0.1642 | Inherited |
Long-chain cytokines | 0.1642 | Inherited |
DBL homology domain (DH-domain) | 0.1852 | Inherited |
MHC antigen-recognition domain | 0.1856 | Inherited |
Integrin domains | 0.1856 | Inherited |
Integrin beta tail domain | 0.2063 | Inherited |
Integrin beta EGF-like domains | 0.2063 | Inherited |
Pyrin domain, PYD | 0.2063 | Inherited |
Integrin alpha N-terminal domain | 0.2214 | Inherited |
Phoshoinositide 3-kinase (PI3K), catalytic domain | 0.2644 | Inherited |
Ngr ectodomain-like | 0.2928 | Inherited |
Complement control module/SCR domain | 0.3548 | Inherited |
Double-stranded RNA-binding domain (dsRBD) | 0.39 | Inherited |
Notch domain | 0.4082 | Inherited |
Cell cycle control phosphatase, catalytic domain | 0.476 | Inherited |
Nuclear receptor ligand-binding domain | 0.4853 | Inherited |
Nuclear receptor | 0.4853 | Inherited |
EGF-type module | 0.5976 | Inherited |
FHA domain | 0.6354 | Inherited |
RING finger domain, C3HC4 | 0.8331 | Inherited |
CCCH zinc finger | 0.8567 | Inherited |
Transforming growth factor (TGF)-beta | 0.8618 | Inherited |
ets domain | 0.8951 | Inherited |
Nicotinic receptor ligand binding domain-like | 0.9351 | Inherited |
Neurotransmitter-gated ion-channel transmembrane pore | 0.9351 | Inherited |
Plot distribution on phylogenetic tree for Superfamily and/or Family domains annotated by this phenotype term
 |
Plot tree as:
| |
Download Newick format tree:
|
(show help)
Trees by TreeVector
A presence/absence matrix is generated using protein domain
architecture data for all genomes in SUPERFAMILY. The PAUP
software is used to produce a single, large tree topology using
heuristic parsimony methods. Genome combinations, or specific clades, can be displayed as
if individual trees had been produced. However, this data is extracted from the single
large tree. This produces a higher quality topology than if the trees had been produced
on their own, and allows the trees to be displayed instantly.
Jump to [ Top · Phenotype Hierarchy · Superfamily · Family · Supra-domain ]
Supra-domain (including individual superfamily)
(show details)
Supra-domains annotated to this MP term (Not in SPMP)
Highlighted in gray are those with FDR>0.001
(show details)
Supra-domains annotated to this MP term (Not in SPMP)
Highlighted in gray are those with FDR>0.001
Supra-domain (Duplex) in N- to C-terminal order |
FDR (all) |
Annotation (direct or inherited) |
48092,47655 48092 - Transcription factor STAT-4 N-domain 47655 - STAT | 0 | DIRECT |
52047,52058 52047 - RNI-like 52058 - L domain-like | 0 | DIRECT |
90188,53649 90188 - Somatomedin B domain 53649 - Alkaline phosphatase-like | 0 | DIRECT |
57586,57586 57586 - TNF receptor-like 57586 - TNF receptor-like | 0 | DIRECT |
49562,57889 49562 - C2 domain (Calcium/lipid-binding domain, CaLB) 57889 - Cysteine-rich domain | 0 | DIRECT |
49417,47719 49417 - p53-like transcription factors 47719 - p53 tetramerization domain | 0 | DIRECT |
49417,55550 49417 - p53-like transcription factors 55550 - SH2 domain | 0 | DIRECT |
57440,56436 57440 - Kringle-like 56436 - C-type lectin-like | 0 | DIRECT |
50370,57440 50370 - Ricin B-like lectins 57440 - Kringle-like | 0 | DIRECT |
47986,52129 47986 - DEATH domain 52129 - Caspase-like | 0 | DIRECT |
49410,50242 49410 - Alpha-macroglobulin receptor domain 50242 - TIMP-like | 0 | DIRECT |
47655,49417 47655 - STAT 49417 - p53-like transcription factors | 0 | DIRECT |
55550,55550 55550 - SH2 domain 55550 - SH2 domain | 0 | DIRECT |
48366,47473 48366 - Ras GEF 47473 - EF-hand | 0 | DIRECT |
47576,48065 47576 - Calponin-homology domain, CH-domain 48065 - DBL homology domain (DH-domain) | 0 | DIRECT |
49417,81296 49417 - p53-like transcription factors 81296 - E set domains | 0.0000254 | DIRECT |
49265,49265 49265 - Fibronectin type III 49265 - Fibronectin type III | 0.001137 | INHERITED FROM: increased circulating interleukin-17 level || altered susceptibility to parasitic infection || altered susceptibility to infection || abnormal leukocyte physiology || abnormal self tolerance || abnormal circulating cytokine level || abnormal IgG2a level || abnormal interferon-gamma secretion || abnormal circulating interferon-gamma level || autoimmune response |
48726,48726 48726 - Immunoglobulin 48726 - Immunoglobulin | 0.002455 | INHERITED FROM: abnormal T cell proliferation || increased anti-nuclear antigen antibody level || autoimmune response || joint inflammation |
47986,47986 47986 - DEATH domain 47986 - DEATH domain | 0.002475 | INHERITED FROM: abnormal adaptive immunity || abnormal immunoglobulin level || abnormal immune cell physiology || abnormal leukocyte physiology || abnormal cell-mediated immunity || abnormal lymphocyte physiology |
57440,50494 57440 - Kringle-like 50494 - Trypsin-like serine proteases | 0.003648 | INHERITED FROM: abnormal macrophage physiology || increased inflammatory response || abnormal inflammatory response || arthritis || abnormal acute phase protein level |
57440,57440 57440 - Kringle-like 57440 - Kringle-like | 0.003648 | INHERITED FROM: increased inflammatory response || abnormal inflammatory response || arthritis || colitis || large intestinal inflammation || joint inflammation |
57924,57924 57924 - Inhibitor of apoptosis (IAP) repeat 57924 - Inhibitor of apoptosis (IAP) repeat | 0.007257 | INHERITED FROM: abnormal B cell apoptosis |
57889,57889 57889 - Cysteine-rich domain 57889 - Cysteine-rich domain | 0.00974 | INHERITED FROM: decreased T cell proliferation |
57603,82895 57603 - FnI-like domain 82895 - TSP-1 type 1 repeat | 0.0205 | INHERITED FROM: abnormal macrophage physiology || abnormal innate immunity |
57944,56436 57944 - Triple coiled coil domain of C-type lectins 56436 - C-type lectin-like | 0.0205 | INHERITED FROM: abnormal response to infection || increased susceptibility to infection || altered susceptibility to infection || abnormal cytokine level |
53300,69318 53300 - vWA-like 69318 - Integrin alpha N-terminal domain | 0.02286 | INHERITED FROM: abnormal T cell proliferation || increased susceptibility to bacterial infection || abnormal T cell activation |
47090,55486 47090 - PGBD-like 55486 - Metalloproteases ("zincins"), catalytic domain | 0.04449 | INHERITED FROM: altered susceptibility to infection || arthritis || altered susceptibility to bacterial infection |
47895,52540 47895 - Transducin (alpha subunit), insertion domain 52540 - P-loop containing nucleoside triphosphate hydrolases | 0.04611 | INHERITED FROM: increased interleukin-2 secretion || abnormal hypersensitivity reaction || increased T cell proliferation |
52058,52058 52058 - L domain-like 52058 - L domain-like | 0.04726 | INHERITED FROM: decreased interleukin-6 secretion |
55550,158235 55550 - SH2 domain 158235 - SOCS box-like | 0.05105 | INHERITED FROM: abnormal interleukin secretion || abnormal cytokine secretion |
50044,55550 50044 - SH3-domain 55550 - SH2 domain | 0.08124 | INHERITED FROM: decreased interleukin-10 secretion || abnormal B cell proliferation || altered susceptibility to infection || abnormal interferon-gamma secretion || decreased interleukin-2 secretion || abnormal T cell activation |
55486,50923 55486 - Metalloproteases ("zincins"), catalytic domain 50923 - Hemopexin-like domain | 0.09286 | INHERITED FROM: altered susceptibility to bacterial infection |
55550,56112 55550 - SH2 domain 56112 - Protein kinase-like (PK-like) | 0.1167 | INHERITED FROM: increased susceptibility to infection || altered susceptibility to infection || abnormal leukocyte physiology || decreased T cell proliferation || abnormal IgG2a level || abnormal interferon-gamma secretion || abnormal interleukin-5 secretion |
55550,50044 55550 - SH2 domain 50044 - SH3-domain | 0.1502 | INHERITED FROM: abnormal NK cell physiology || abnormal IgG2 level || abnormal interleukin-2 secretion || decreased B cell proliferation || abnormal IgG2b level || abnormal T cell proliferation || decreased interleukin-10 secretion || abnormal B cell activation || abnormal B cell proliferation || decreased IgG1 level || decreased immunoglobulin level || decreased tumor necrosis factor secretion || abnormal leukocyte physiology || abnormal cytokine secretion || abnormal lymphocyte physiology || abnormal IgG1 level || abnormal IgG3 level || abnormal interferon-gamma secretion || decreased IgG2 level || abnormal IgM level || abnormal interferon secretion || decreased interleukin-2 secretion || decreased interferon-gamma secretion || decreased IgG3 level || decreased IgG2b level || decreased IgM level || abnormal T cell activation |
48065,50729 48065 - DBL homology domain (DH-domain) 50729 - PH domain-like | 0.1788 | INHERITED FROM: decreased B cell proliferation || decreased interleukin-2 secretion |
47986,52540 47986 - DEATH domain 52540 - P-loop containing nucleoside triphosphate hydrolases | 0.1907 | INHERITED FROM: abnormal adaptive immunity || intestinal inflammation || abnormal susceptibility to induced colitis || decreased susceptibility to autoimmune disorder || abnormal interleukin secretion || abnormal immune cell physiology || decreased acute inflammation || abnormal leukocyte physiology || abnormal interleukin-1 beta secretion || colitis || abnormal cell-mediated immunity || increased susceptibility to bacterial infection || large intestinal inflammation || abnormal immune serum protein physiology || abnormal circulating interleukin level |
57196,69687 57196 - EGF/Laminin 69687 - Integrin beta tail domain | 0.1907 | INHERITED FROM: increased inflammatory response || abnormal inflammatory response || abnormal leukocyte migration |
69318,69179 69318 - Integrin alpha N-terminal domain 69179 - Integrin domains | 0.202 | INHERITED FROM: abnormal cellular extravasation |
69179,69179 69179 - Integrin domains 69179 - Integrin domains | 0.202 | INHERITED FROM: abnormal cellular extravasation |
53300,69179 53300 - vWA-like 69179 - Integrin domains | 0.2414 | INHERITED FROM: increased inflammatory response || abnormal inflammatory response || abnormal leukocyte migration |
54452,48726 54452 - MHC antigen-recognition domain 48726 - Immunoglobulin | 0.269 | INHERITED FROM: abnormal B lymphocyte antigen presentation || abnormal antigen presentation || altered susceptibility to infection || abnormal leukocyte physiology || abnormal self tolerance || abnormal cytotoxic T cell physiology || abnormal lymphocyte physiology || altered susceptibility to autoimmune disorder || abnormal interferon-gamma secretion || abnormal interferon secretion || autoimmune response |
54768,54768 54768 - dsRNA-binding domain-like 54768 - dsRNA-binding domain-like | 0.3061 | INHERITED FROM: increased susceptibility to viral infection || altered susceptibility to viral infection |
52821,52799 52821 - Rhodanese/Cell cycle control phosphatase 52799 - (Phosphotyrosine protein) phosphatases II | 0.3065 | INHERITED FROM: increased tumor necrosis factor secretion |
57535,57535 57535 - Complement control module/SCR domain 57535 - Complement control module/SCR domain | 0.3638 | INHERITED FROM: impaired leukocyte tethering or rolling || abnormal leukocyte adhesion || abnormal eosinophil physiology || impaired eosinophil recruitment || abnormal leukocyte tethering or rolling || abnormal cellular extravasation || abnormal complement pathway || abnormal innate immunity || impaired neutrophil recruitment || abnormal humoral immune response |
52799,49562 52799 - (Phosphotyrosine protein) phosphatases II 49562 - C2 domain (Calcium/lipid-binding domain, CaLB) | 0.3889 | INHERITED FROM: kidney inflammation || renal/urinary system inflammation |
57196,57196 57196 - EGF/Laminin 57196 - EGF/Laminin | 0.3943 | INHERITED FROM: increased inflammatory response |
50729,55550 50729 - PH domain-like 55550 - SH2 domain | 0.6676 | INHERITED FROM: abnormal IgG level |
57716,48508 57716 - Glucocorticoid receptor-like (DNA-binding domain) 48508 - Nuclear receptor ligand-binding domain | 0.7121 | INHERITED FROM: increased inflammatory response |
63712,90112 63712 - Nicotinic receptor ligand binding domain-like 90112 - Neurotransmitter-gated ion-channel transmembrane pore | 0.9126 | INHERITED FROM: urinary bladder inflammation |
Supra-domain (Duplex) in N- to C-terminal order |
FDR (all) |
Annotation (direct or inherited) |
48092,47655 48092 - Transcription factor STAT-4 N-domain 47655 - STAT | 0 | Direct |
52047,52058 52047 - RNI-like 52058 - L domain-like | 0 | Direct |
90188,53649 90188 - Somatomedin B domain 53649 - Alkaline phosphatase-like | 0 | Direct |
57586,57586 57586 - TNF receptor-like 57586 - TNF receptor-like | 0 | Direct |
49562,57889 49562 - C2 domain (Calcium/lipid-binding domain, CaLB) 57889 - Cysteine-rich domain | 0 | Direct |
49417,47719 49417 - p53-like transcription factors 47719 - p53 tetramerization domain | 0 | Direct |
49417,55550 49417 - p53-like transcription factors 55550 - SH2 domain | 0 | Direct |
57440,56436 57440 - Kringle-like 56436 - C-type lectin-like | 0 | Direct |
50370,57440 50370 - Ricin B-like lectins 57440 - Kringle-like | 0 | Direct |
47986,52129 47986 - DEATH domain 52129 - Caspase-like | 0 | Direct |
49410,50242 49410 - Alpha-macroglobulin receptor domain 50242 - TIMP-like | 0 | Direct |
47655,49417 47655 - STAT 49417 - p53-like transcription factors | 0 | Direct |
55550,55550 55550 - SH2 domain 55550 - SH2 domain | 0 | Direct |
48366,47473 48366 - Ras GEF 47473 - EF-hand | 0 | Direct |
47576,48065 47576 - Calponin-homology domain, CH-domain 48065 - DBL homology domain (DH-domain) | 0 | Direct |
49417,81296 49417 - p53-like transcription factors 81296 - E set domains | 0.0000254 | Direct |
49265,49265 49265 - Fibronectin type III 49265 - Fibronectin type III | 0.001137 | Inherited |
48726,48726 48726 - Immunoglobulin 48726 - Immunoglobulin | 0.002455 | Inherited |
47986,47986 47986 - DEATH domain 47986 - DEATH domain | 0.002475 | Inherited |
57440,50494 57440 - Kringle-like 50494 - Trypsin-like serine proteases | 0.003648 | Inherited |
57440,57440 57440 - Kringle-like 57440 - Kringle-like | 0.003648 | Inherited |
57924,57924 57924 - Inhibitor of apoptosis (IAP) repeat 57924 - Inhibitor of apoptosis (IAP) repeat | 0.007257 | Inherited |
57889,57889 57889 - Cysteine-rich domain 57889 - Cysteine-rich domain | 0.00974 | Inherited |
57603,82895 57603 - FnI-like domain 82895 - TSP-1 type 1 repeat | 0.0205 | Inherited |
57944,56436 57944 - Triple coiled coil domain of C-type lectins 56436 - C-type lectin-like | 0.0205 | Inherited |
53300,69318 53300 - vWA-like 69318 - Integrin alpha N-terminal domain | 0.02286 | Inherited |
47090,55486 47090 - PGBD-like 55486 - Metalloproteases ("zincins"), catalytic domain | 0.04449 | Inherited |
47895,52540 47895 - Transducin (alpha subunit), insertion domain 52540 - P-loop containing nucleoside triphosphate hydrolases | 0.04611 | Inherited |
52058,52058 52058 - L domain-like 52058 - L domain-like | 0.04726 | Inherited |
55550,158235 55550 - SH2 domain 158235 - SOCS box-like | 0.05105 | Inherited |
50044,55550 50044 - SH3-domain 55550 - SH2 domain | 0.08124 | Inherited |
55486,50923 55486 - Metalloproteases ("zincins"), catalytic domain 50923 - Hemopexin-like domain | 0.09286 | Inherited |
55550,56112 55550 - SH2 domain 56112 - Protein kinase-like (PK-like) | 0.1167 | Inherited |
55550,50044 55550 - SH2 domain 50044 - SH3-domain | 0.1502 | Inherited |
48065,50729 48065 - DBL homology domain (DH-domain) 50729 - PH domain-like | 0.1788 | Inherited |
47986,52540 47986 - DEATH domain 52540 - P-loop containing nucleoside triphosphate hydrolases | 0.1907 | Inherited |
57196,69687 57196 - EGF/Laminin 69687 - Integrin beta tail domain | 0.1907 | Inherited |
69318,69179 69318 - Integrin alpha N-terminal domain 69179 - Integrin domains | 0.202 | Inherited |
69179,69179 69179 - Integrin domains 69179 - Integrin domains | 0.202 | Inherited |
53300,69179 53300 - vWA-like 69179 - Integrin domains | 0.2414 | Inherited |
54452,48726 54452 - MHC antigen-recognition domain 48726 - Immunoglobulin | 0.269 | Inherited |
54768,54768 54768 - dsRNA-binding domain-like 54768 - dsRNA-binding domain-like | 0.3061 | Inherited |
52821,52799 52821 - Rhodanese/Cell cycle control phosphatase 52799 - (Phosphotyrosine protein) phosphatases II | 0.3065 | Inherited |
57535,57535 57535 - Complement control module/SCR domain 57535 - Complement control module/SCR domain | 0.3638 | Inherited |
52799,49562 52799 - (Phosphotyrosine protein) phosphatases II 49562 - C2 domain (Calcium/lipid-binding domain, CaLB) | 0.3889 | Inherited |
57196,57196 57196 - EGF/Laminin 57196 - EGF/Laminin | 0.3943 | Inherited |
50729,55550 50729 - PH domain-like 55550 - SH2 domain | 0.6676 | Inherited |
57716,48508 57716 - Glucocorticoid receptor-like (DNA-binding domain) 48508 - Nuclear receptor ligand-binding domain | 0.7121 | Inherited |
63712,90112 63712 - Nicotinic receptor ligand binding domain-like 90112 - Neurotransmitter-gated ion-channel transmembrane pore | 0.9126 | Inherited |
(show details)
Supra-domains annotated to this MP term (Not in SPMP)
Highlighted in gray are those with FDR>0.001
Supra-domain (Triple) in N- to C-terminal order |
FDR (all) |
Annotation (direct or inherited) |
50729,50044,55550 50729 - PH domain-like 50044 - SH3-domain 55550 - SH2 domain | 0 | DIRECT |
57850,49599,49599 57850 - RING/U-box 49599 - TRAF domain-like 49599 - TRAF domain-like | 0 | DIRECT |
56436,56436,56436 56436 - C-type lectin-like 56436 - C-type lectin-like 56436 - C-type lectin-like | 0 | DIRECT |
48092,47655,49417 48092 - Transcription factor STAT-4 N-domain 47655 - STAT 49417 - p53-like transcription factors | 0 | DIRECT |
50370,57440,56436 50370 - Ricin B-like lectins 57440 - Kringle-like 56436 - C-type lectin-like | 0 | DIRECT |
57586,57586,57586 57586 - TNF receptor-like 57586 - TNF receptor-like 57586 - TNF receptor-like | 0 | DIRECT |
47655,49417,55550 47655 - STAT 49417 - p53-like transcription factors 55550 - SH2 domain | 0 | DIRECT |
90188,90188,53649 90188 - Somatomedin B domain 90188 - Somatomedin B domain 53649 - Alkaline phosphatase-like | 0 | DIRECT |
49562,57889,57889 49562 - C2 domain (Calcium/lipid-binding domain, CaLB) 57889 - Cysteine-rich domain 57889 - Cysteine-rich domain | 0 | DIRECT |
48366,47473,57889 48366 - Ras GEF 47473 - EF-hand 57889 - Cysteine-rich domain | 0 | DIRECT |
57440,56436,56436 57440 - Kringle-like 56436 - C-type lectin-like 56436 - C-type lectin-like | 0 | DIRECT |
50044,55550,50044 50044 - SH3-domain 55550 - SH2 domain 50044 - SH3-domain | 0 | DIRECT |
47576,48065,50729 47576 - Calponin-homology domain, CH-domain 48065 - DBL homology domain (DH-domain) 50729 - PH domain-like | 0 | DIRECT |
57440,57440,57440 57440 - Kringle-like 57440 - Kringle-like 57440 - Kringle-like | 0.007257 | INHERITED FROM: increased inflammatory response || abnormal inflammatory response || colitis || large intestinal inflammation |
57924,57924,57924 57924 - Inhibitor of apoptosis (IAP) repeat 57924 - Inhibitor of apoptosis (IAP) repeat 57924 - Inhibitor of apoptosis (IAP) repeat | 0.007257 | INHERITED FROM: abnormal B cell apoptosis |
57440,57440,50494 57440 - Kringle-like 57440 - Kringle-like 50494 - Trypsin-like serine proteases | 0.007257 | INHERITED FROM: abnormal macrophage physiology || increased inflammatory response || abnormal inflammatory response |
53300,69318,69179 53300 - vWA-like 69318 - Integrin alpha N-terminal domain 69179 - Integrin domains | 0.02286 | INHERITED FROM: abnormal T cell proliferation || increased susceptibility to bacterial infection || abnormal T cell activation |
47090,55486,50923 47090 - PGBD-like 55486 - Metalloproteases ("zincins"), catalytic domain 50923 - Hemopexin-like domain | 0.09286 | INHERITED FROM: altered susceptibility to bacterial infection |
69179,69179,69179 69179 - Integrin domains 69179 - Integrin domains 69179 - Integrin domains | 0.09286 | INHERITED FROM: abnormal cellular extravasation |
50044,55550,56112 50044 - SH3-domain 55550 - SH2 domain 56112 - Protein kinase-like (PK-like) | 0.1373 | INHERITED FROM: abnormal IgG2 level || increased susceptibility to infection || altered susceptibility to infection || abnormal leukocyte physiology || decreased T cell proliferation || abnormal IgG2a level || abnormal interleukin-5 secretion |
57196,57196,69687 57196 - EGF/Laminin 57196 - EGF/Laminin 69687 - Integrin beta tail domain | 0.1907 | INHERITED FROM: increased inflammatory response || abnormal inflammatory response || abnormal leukocyte migration |
49265,49265,49265 49265 - Fibronectin type III 49265 - Fibronectin type III 49265 - Fibronectin type III | 0.1907 | INHERITED FROM: increased IgG level |
69318,69179,69179 69318 - Integrin alpha N-terminal domain 69179 - Integrin domains 69179 - Integrin domains | 0.202 | INHERITED FROM: abnormal cellular extravasation |
57535,57535,57535 57535 - Complement control module/SCR domain 57535 - Complement control module/SCR domain 57535 - Complement control module/SCR domain | 0.3491 | INHERITED FROM: abnormal complement pathway || abnormal humoral immune response |
55550,56112,56112 55550 - SH2 domain 56112 - Protein kinase-like (PK-like) 56112 - Protein kinase-like (PK-like) | 0.3889 | INHERITED FROM: abnormal immunoglobulin level || abnormal IgG level || abnormal humoral immune response || abnormal B cell physiology |
50729,55550,56112 50729 - PH domain-like 55550 - SH2 domain 56112 - Protein kinase-like (PK-like) | 0.3889 | INHERITED FROM: abnormal immunoglobulin level || abnormal IgG level || abnormal humoral immune response || abnormal B cell physiology |
57184,57196,57196 57184 - Growth factor receptor domain 57196 - EGF/Laminin 57196 - EGF/Laminin | 0.4909 | INHERITED FROM: abnormal interleukin-4 secretion || decreased interleukin-4 secretion |
57196,57196,57184 57196 - EGF/Laminin 57196 - EGF/Laminin 57184 - Growth factor receptor domain | 0.6941 | INHERITED FROM: abnormal interleukin-4 secretion || decreased interleukin-4 secretion |
Supra-domain (Triple) in N- to C-terminal order |
FDR (all) |
Annotation (direct or inherited) |
50729,50044,55550 50729 - PH domain-like 50044 - SH3-domain 55550 - SH2 domain | 0 | Direct |
57850,49599,49599 57850 - RING/U-box 49599 - TRAF domain-like 49599 - TRAF domain-like | 0 | Direct |
56436,56436,56436 56436 - C-type lectin-like 56436 - C-type lectin-like 56436 - C-type lectin-like | 0 | Direct |
48092,47655,49417 48092 - Transcription factor STAT-4 N-domain 47655 - STAT 49417 - p53-like transcription factors | 0 | Direct |
50370,57440,56436 50370 - Ricin B-like lectins 57440 - Kringle-like 56436 - C-type lectin-like | 0 | Direct |
57586,57586,57586 57586 - TNF receptor-like 57586 - TNF receptor-like 57586 - TNF receptor-like | 0 | Direct |
47655,49417,55550 47655 - STAT 49417 - p53-like transcription factors 55550 - SH2 domain | 0 | Direct |
90188,90188,53649 90188 - Somatomedin B domain 90188 - Somatomedin B domain 53649 - Alkaline phosphatase-like | 0 | Direct |
49562,57889,57889 49562 - C2 domain (Calcium/lipid-binding domain, CaLB) 57889 - Cysteine-rich domain 57889 - Cysteine-rich domain | 0 | Direct |
48366,47473,57889 48366 - Ras GEF 47473 - EF-hand 57889 - Cysteine-rich domain | 0 | Direct |
57440,56436,56436 57440 - Kringle-like 56436 - C-type lectin-like 56436 - C-type lectin-like | 0 | Direct |
50044,55550,50044 50044 - SH3-domain 55550 - SH2 domain 50044 - SH3-domain | 0 | Direct |
47576,48065,50729 47576 - Calponin-homology domain, CH-domain 48065 - DBL homology domain (DH-domain) 50729 - PH domain-like | 0 | Direct |
57440,57440,57440 57440 - Kringle-like 57440 - Kringle-like 57440 - Kringle-like | 0.007257 | Inherited |
57924,57924,57924 57924 - Inhibitor of apoptosis (IAP) repeat 57924 - Inhibitor of apoptosis (IAP) repeat 57924 - Inhibitor of apoptosis (IAP) repeat | 0.007257 | Inherited |
57440,57440,50494 57440 - Kringle-like 57440 - Kringle-like 50494 - Trypsin-like serine proteases | 0.007257 | Inherited |
53300,69318,69179 53300 - vWA-like 69318 - Integrin alpha N-terminal domain 69179 - Integrin domains | 0.02286 | Inherited |
47090,55486,50923 47090 - PGBD-like 55486 - Metalloproteases ("zincins"), catalytic domain 50923 - Hemopexin-like domain | 0.09286 | Inherited |
69179,69179,69179 69179 - Integrin domains 69179 - Integrin domains 69179 - Integrin domains | 0.09286 | Inherited |
50044,55550,56112 50044 - SH3-domain 55550 - SH2 domain 56112 - Protein kinase-like (PK-like) | 0.1373 | Inherited |
57196,57196,69687 57196 - EGF/Laminin 57196 - EGF/Laminin 69687 - Integrin beta tail domain | 0.1907 | Inherited |
49265,49265,49265 49265 - Fibronectin type III 49265 - Fibronectin type III 49265 - Fibronectin type III | 0.1907 | Inherited |
69318,69179,69179 69318 - Integrin alpha N-terminal domain 69179 - Integrin domains 69179 - Integrin domains | 0.202 | Inherited |
57535,57535,57535 57535 - Complement control module/SCR domain 57535 - Complement control module/SCR domain 57535 - Complement control module/SCR domain | 0.3491 | Inherited |
55550,56112,56112 55550 - SH2 domain 56112 - Protein kinase-like (PK-like) 56112 - Protein kinase-like (PK-like) | 0.3889 | Inherited |
50729,55550,56112 50729 - PH domain-like 55550 - SH2 domain 56112 - Protein kinase-like (PK-like) | 0.3889 | Inherited |
57184,57196,57196 57184 - Growth factor receptor domain 57196 - EGF/Laminin 57196 - EGF/Laminin | 0.4909 | Inherited |
57196,57196,57184 57196 - EGF/Laminin 57196 - EGF/Laminin 57184 - Growth factor receptor domain | 0.6941 | Inherited |
Plot distribution on phylogenetic tree for Supra-domains (Single/Individual) annotated by this phenotype term
 |
Plot tree as:
| |
Download Newick format tree:
|
(show help)
Trees by TreeVector
A presence/absence matrix is generated using protein domains and supradomains
for all genomes in SUPERFAMILY. The RAxML
software is used to produce a single, large tree topology using
heuristic parsimony methods. Genome combinations, or specific clades, can be displayed as
if individual trees had been produced. However, this data is extracted from the single
large tree. This produces a higher quality topology than if the trees had been produced
on their own, and allows the trees to be displayed instantly.
|